Co-Diagnostics, Inc. Common Stock
CODX
$0.94-17.47%
End of day · as of Sep 17, 2026, 2:45 AM ET
Mkt cap
$31.44M
EV/Sales
31.4
P/E ratio
N/A
FY2025 Revenue
$622,489
EPS (TTM)
$-39.47
Gross Margin (FY2025)
64.28%
Profit Margin (FY2025)
-7533.62%
Beta
1.26
Div yield
N/A
Sector
Healthcare
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported CODX revenue for 2025-12-31 was $622.5K. Net income was -$46.9M. Revenue was down 84.1% from 2024-12-31 to 2025-12-31. CODX currently screens at market cap $31.4M.
Use this CODX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CODX income, balance, and cash tables.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company in the Healthcare sector.
Latest cached Co-Diagnostics, Inc. Common Stock (CODX) revenue for Dec 31, 2025 was $622.5K. Net income was -$46.9M. Statements: https://lician.com/financials/codx
Co-Diagnostics, Inc. Common Stock (CODX) market capitalization is $31.4M on the latest cached snapshot.
Co-Diagnostics, Inc. Common Stock (CODX) cached previous close $1.14; day range $0.93 – $1.10; volume 1,531,905. Session quote: https://lician.com/quote/codx
Co-Diagnostics, Inc. Common Stock (CODX) latest cached earnings event is "CODX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CODX filing is 8-K/A · Oct 15, 2026. Filings: https://lician.com/sec/codx